QT Imaging (NASDAQ:QTI) Stock Price Down 0.5% – Here’s Why

Shares of QT Imaging Holdings, Inc. (NASDAQ:QTI) traded down 0.5% during mid-day trading on Thursday . The stock traded as low as $3.69 and last traded at $3.71. Approximately 12,731 shares were traded during mid-day trading, a decline of 59% from the average session volume of 31,016 shares. The stock had previously closed at $3.73.

Analyst Upgrades and Downgrades

QTI has been the subject of several research reports. Wall Street Zen upgraded QT Imaging to a “hold” rating in a research note on Saturday, May 16th. Zacks Research raised QT Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold”.

QT Imaging Price Performance

The stock’s fifty day moving average price is $4.79 and its 200-day moving average price is $5.62. The firm has a market cap of $51.09 million, a PE ratio of -2.99 and a beta of -0.04. The company has a debt-to-equity ratio of 1.38, a current ratio of 2.49 and a quick ratio of 1.69.

QT Imaging (NASDAQ:QTI) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.11). The business had revenue of $6.53 million during the quarter, compared to analysts’ expectations of $6.45 million. QT Imaging had a negative return on equity of 4,220.38% and a negative net margin of 58.93%. As a group, equities analysts expect that QT Imaging Holdings, Inc. will post -0.59 EPS for the current fiscal year.

About QT Imaging

QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.

QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.